Semaglutide offered the most pronounced chemoprotective effects, with the effects of all GLP‐1 RAs generally greater in younger adult patients of white ethnicity, living with obesity, and in those with longer duration T2D. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.